Diagnostic and prognostic importance of EPAS-1 in acute pulmonary embolism
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
Objective: Our aim in this study is to reveal the changes in EPAS-1 levels, a biomarker proven to increase with hypoxia, at the time of diagnosis and after treatment, in addition to the laboratory parameters and scoring systems examined at the time of admission in patients with pulmonary thromboembolism. Materials and Methods: Our study included 60 diagnosed pulmonary embolism patients who were followed up in the Cardiology clinic and 60 control groups with similar demographic characteristics who were examined in the Cardiology outpatient clinic and did not have pulmonary embolism. Laboratory parameters determined at the time of admission were examined, and electrocardiographic and echocardiographic measurements were recorded. Additionally, pulmonary embolism risk and severity scores were applied and EPAS-1 levels were studied. To determine the treatment response, EPAS-1 levels were checked after 3 days and compared with the control group. Results: There was no difference between the two groups in terms of demographic characteristics, hypertension, diabetes mellitus, coronary artery disease and lung disease. EPAS-1 levels were found to be higher at the time of diagnosis compared to the control group ((3.6±1.42/1.57±0,45), p<0.001). It showed a statistically significant positive correlation with PESI severity score and risk score in the patient group. It was shown that EPAS-1 levels decreased with the treatments of the patients and their tendency to decrease was different depending on the treatment types. It was shown that EPAS-1 levels continued to increase in patients who died despite treatment (p:0.014). Conclusion: There is currently no biomarker that can be used as a diagnostic or exclusion criterion in patients with pulmonary thromboembolism. EPAS-1 levels were found to be increased in pulmonary embolism patients at the time of diagnosis, and were shown to decrease after the success of medical treatment. Our study is important in that EPAS-1 levels, which are significant and correlated with scoring systems and other laboratory parameters used in pulmonary embolism patients, can be used as a predictive value in the diagnosis process of the disease and play a complementary role in the evaluation of treatment response.
Author
Ahmet Taha Şahin
How to Cite
Ahmet Taha Şahin (Medical Specialty Thesis). Diagnostic and prognostic importance of EPAS-1 in acute pulmonary embolism, 2023, Necmettin Erbakan University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Necmettin Erbakan University
- The effects of capital structure decisions on the financial performance of banks: An application on the banking sector of Afghanistan(2023)
- An investigation of the level of inclusion of lifelong learning skills in the 3rd grade science textbook(2023)
- Investigating the effect of 5E learning model supported digital worksheets on 4th grade students' measurement sense(2023)
- Analysing the relationship between emotional intelligence, cognitive flexibility and psychological well-being levels of university students(2023)
- Turkish music mades and features used in treatment from past to present(2023)
- The mediating role of social media addiction and phubbing in basic psychological needs in relationships and relationship satisfaction(2023)
